145 related articles for article (PubMed ID: 31069490)
1. Second primary uterine malignancies after radiation therapy for cervical cancer.
Papatla K; Houck KL; Hernandez E; Chu C; Rubin S
Arch Gynecol Obstet; 2019 Aug; 300(2):389-394. PubMed ID: 31069490
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific outcome of metachronous uterine malignancy after pelvic irradiation for cervical cancer.
Matsuo K; Machida H; Mandelbaum RS; Ragab OM; Roman LD; Wright JD
Gynecol Oncol; 2018 Nov; 151(2):250-256. PubMed ID: 30197062
[TBL] [Abstract][Full Text] [Related]
3. Does muscle invasive bladder cancer following pelvic radiotherapy portend worse prognosis? A seer-based study.
Natale C; Leinwand G; Zeineddine F; Silberstein JL; Krane LS
Cancer Treat Res Commun; 2020; 24():100177. PubMed ID: 32454387
[TBL] [Abstract][Full Text] [Related]
4. Development of endometrial cancer following radiation therapy for cervical carcinoma.
Hagiwara T; Mori T; Kaku T
Eur J Gynaecol Oncol; 2005; 26(2):191-5. PubMed ID: 15857027
[TBL] [Abstract][Full Text] [Related]
5. Development of endometrial cancer after radiation treatment for cervical carcinoma.
Pothuri B; Ramondetta L; Martino M; Alektiar K; Eifel PJ; Deavers MT; Venkatraman E; Soslow RA; Barakat RR
Obstet Gynecol; 2003 May; 101(5 Pt 1):941-5. PubMed ID: 12738155
[TBL] [Abstract][Full Text] [Related]
6. Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers.
Pothuri B; Ramondetta L; Eifel P; Deavers MT; Wilton A; Alektiar K; Barakat R; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):948-51. PubMed ID: 16870239
[TBL] [Abstract][Full Text] [Related]
7. The risk of subsequent malignancies in women with uterine papillary serous or clear cell endometrial cancers.
Hinshaw HD; Smith A; Rungruang B; Kelley JL; Beriwal S; Krivak TC; Sukumvanich P; Olawaiye AB
Int J Gynecol Cancer; 2013 Jul; 23(6):1044-9. PubMed ID: 23748174
[TBL] [Abstract][Full Text] [Related]
8. Risk of colorectal cancer among long-term cervical cancer survivors.
Rodriguez AM; Kuo YF; Goodwin JS
Med Oncol; 2014 May; 31(5):943. PubMed ID: 24696219
[TBL] [Abstract][Full Text] [Related]
9. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
Chaturvedi AK; Engels EA; Gilbert ES; Chen BE; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fosså SD; Joensuu H; Boice JD; Kleinerman RA; Travis LB
J Natl Cancer Inst; 2007 Nov; 99(21):1634-43. PubMed ID: 17971527
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma.
Werner-Wasik M; Schmid CH; Bornstein LE; Madoc-Jones H
Cancer; 1995 May; 75(9):2281-5. PubMed ID: 7712437
[TBL] [Abstract][Full Text] [Related]
11. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
[TBL] [Abstract][Full Text] [Related]
12. Uterine carcinomas simulating microglandular hyperplasia. A report of six cases.
Young RH; Scully RE
Am J Surg Pathol; 1992 Nov; 16(11):1092-7. PubMed ID: 1471729
[TBL] [Abstract][Full Text] [Related]
13. Uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature review.
Behtash N; Hashemi R; Karimi Zarchi M
Asian Pac J Cancer Prev; 2009; 10(1):163-6. PubMed ID: 19469647
[TBL] [Abstract][Full Text] [Related]
14. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
15. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
[TBL] [Abstract][Full Text] [Related]
16. Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis.
Warschkow R; Güller U; Cerny T; Schmied BM; Plasswilm L; Putora PM
Radiother Oncol; 2017 Apr; 123(1):139-146. PubMed ID: 28285840
[TBL] [Abstract][Full Text] [Related]
17. Uterine papillary serous carcinoma after pelvic radiation therapy for cancer of the cervix.
Behtash N; Tehranian A; Ardalan FA; Hanjani P
J Obstet Gynaecol; 2002 Jan; 22(1):96-7. PubMed ID: 12521747
[TBL] [Abstract][Full Text] [Related]
18. Risk for colorectal cancer after gynecologic cancer.
Weinberg DS; Newschaffer CJ; Topham A
Ann Intern Med; 1999 Aug; 131(3):189-93. PubMed ID: 10428735
[TBL] [Abstract][Full Text] [Related]
19. Relationship between tamoxifen use and high risk endometrial cancer histologic types.
Bland AE; Calingaert B; Secord AA; Lee PS; Valea FA; Berchuck A; Soper JT; Havrilesky L
Gynecol Oncol; 2009 Jan; 112(1):150-4. PubMed ID: 18937966
[TBL] [Abstract][Full Text] [Related]
20. [Follow-up after malignant tumours of the uterus (cancer of the uterine corpus / cervical cancer)].
Johann S; Mueller MD
Ther Umsch; 2008 Jun; 65(6):341-6. PubMed ID: 18622958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
